PubRank

R Ralston

Author PubWeight™ 43.91‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Vaccination of chimpanzees against infection by the hepatitis C virus. Proc Natl Acad Sci U S A 1994 3.76
2 Intrahepatic cytotoxic T lymphocytes specific for hepatitis C virus in persons with chronic hepatitis. J Immunol 1992 3.13
3 Molecular cloning and in vitro expression of a cDNA clone for human cellular tumor antigen p53. Mol Cell Biol 1985 3.09
4 Characterization of the hepatitis C virus E2/NS1 gene product expressed in mammalian cells. Virology 1992 2.58
5 Hepatitis C virus (HCV)-specific cytotoxic T lymphocytes recognize epitopes in the core and envelope proteins of HCV. J Virol 1993 2.57
6 Human papillomavirus (HPV) type distribution and serological response to HPV type 6 virus-like particles in patients with genital warts. J Clin Microbiol 1995 2.46
7 The protein products of the myc and myb oncogenes and adenovirus E1a are structurally related. Nature 1984 2.25
8 The product of the protooncogene c-src is modified during the cellular response to platelet-derived growth factor. Proc Natl Acad Sci U S A 1985 2.19
9 Subcellular location of an abundant substrate (p36) for tyrosine-specific protein kinases. Mol Cell Biol 1983 1.61
10 Hepatitis C virus-specific CTL responses in the liver of chimpanzees with acute and chronic hepatitis C. J Immunol 1993 1.57
11 Intratumoral injection of an adenovirus expressing interleukin 2 induces regression and immunity in a murine breast cancer model. Proc Natl Acad Sci U S A 1995 1.56
12 Systemic inhibition of tumor growth and tumor metastases by intramuscular administration of the endostatin gene. Nat Biotechnol 1999 1.41
13 Regulation of protein synthesis in rabbit reticulocyte lysates by the heme-regulated protein kinase: inhibition of interaction of Met-tRNAfMet binding factor with another initiation factor in formation of Met-tRNAfMet.40S ribosomal subunit complexes. Proc Natl Acad Sci U S A 1978 1.39
14 The p36 substrate of tyrosine-specific protein kinases co-localizes with non-erythrocyte alpha-spectrin antigen, p230, in surface lamina of cultured fibroblasts. EMBO J 1983 1.36
15 The membrane glycoprotein encoded by the retroviral oncogene v-erb-B is structurally related to tyrosine-specific protein kinases. Proc Natl Acad Sci U S A 1984 1.23
16 Expression and characterization of recombinant hepatitis A virus 3C proteinase. Biochemistry 1992 1.22
17 Persistence of HCV despite antibodies to both putative envelope glycoproteins. Lancet 1993 1.17
18 Peptide immunogen mimicry of putative E1 glycoprotein-specific epitopes in hepatitis C virus. J Virol 1994 1.07
19 Mutations selected in the hepatitis C virus NS3 protease domain during sequential treatment with boceprevir with and without pegylated interferon alfa-2b. J Viral Hepat 2011 1.03
20 Protein synthesis in rabbit reticulocytes XXI. Purification and properties of a protein factor (Co-EIF-1) which stimulates Met-tRNAf binding to EIF-1. J Biol Chem 1978 0.94
21 Preclinical characterization of the antiviral activity of SCH 900518 (narlaprevir), a novel mechanism-based inhibitor of hepatitis C virus NS3 protease. Antimicrob Agents Chemother 2010 0.92
22 Quantitative genetics of age-related retinal degeneration: a second F1 intercross between the A/J and C57BL/6 strains. Mol Vis 2007 0.90
23 A peptide derived from hepatitis C virus E2 envelope protein inhibits a post-binding step in HCV entry. Antiviral Res 2010 0.88
24 Specific depletion of human anti-adenovirus antibodies facilitates transduction in an in vivo model for systemic gene therapy. Mol Ther 2001 0.86
25 Protein synthesis in rabbit reticulocytes XXII+: a heat stable dialyzable factor (EIF-I*) modulates Met-tRNAf binding to EIF-1. Biochem Biophys Res Commun 1978 0.81
26 Cell cycle-dependent disruption of E2F-p107 complexes by human papillomavirus type 16 E7. J Gen Virol 1995 0.80
27 The CXXC Zn binding motifs of the human papillomavirus type 16 E7 oncoprotein are not required for its in vitro transforming activity in rodent cells. Oncogene 1998 0.79
28 Combination surgery and nonviral interleukin 2 gene therapy for head and neck cancer. Clin Cancer Res 1999 0.76
29 Prospects for prophylactic and therapeutic hepatitis C virus vaccines. Princess Takamatsu Symp 1995 0.75
30 Heat stroke. Minn Med 1976 0.75
31 Aiming for excellence. Setting up woman-centred care at Ayrshire Central Maternity Hospital. Pract Midwife 1999 0.75
32 Pediatric intensive care nursing takes special nursing giving special care - a bond is formed between child and nurse. Pa Nurse 1984 0.75
33 Purification and properties of rabbit reticulocyte initiation factor Co-EIF-1. Methods Enzymol 1979 0.75